Search
for
Sort by
Research 61–90 of 892
- Flares of systemic lupus erythematosus during pregnancy and the puerperium: prevention, diagnosis and management
- Repurposing of approved cardiovascular drugs
- Controversies in plastic surgery: Suction-assisted lipectomy (SAL) and the hCG (human chorionic gonadotropin) protocol for obesity treatment
- The pharmacovigilance analysis of adverse events of erlotinib based on the open access FAERS database
- Androgen Treatment in Women
- Hair Depigmentation Is a Biological Readout for Pharmacological Inhibition of KIT in Mice and Humans
- [4-t-Butylphenyl]-N-(4-imidazol-1-yl phenyl)sulfonamide (ISCK03) inhibits SCF/c-kit signaling in 501mel human melanoma cells and abolishes melanin production in mice and brownish guinea pigs
- Clinical Development of Topoisomerase-Interactive Drugs
- Evidence-Based and Potential Benefits of Metformin in the Polycystic Ovary Syndrome: A Comprehensive Review
- Mucocutaneous reactions to chemotherapy
- Historical and Current Adenosine Receptor Agonists in Preclinical and Clinical Development
- Androgen Signaling Regulates SARS-CoV-2 Receptor Levels and Is Associated with Severe COVID-19 Symptoms in Men
- An Open-Label Pilot Study to Evaluate the Efficacy of Tofacitinib in Moderate to Severe Patch-Type Alopecia Areata, Totalis, and Universalis
- K channel therapeutics at the bedside
- Follicular delivery of spironolactone via nanostructured lipid carriers for management of alopecia
- Liposomes and niosomes as potential carriers for dermal delivery of minoxidil
- Extracellular vesicle-based drug overview: research landscape, quality control and nonclinical evaluation strategies
- What do we know about phytotherapy of benign prostatic hyperplasia?
- Alisertib is active as single agent in recurrent atypical teratoid rhabdoid tumors in 4 children
- Review article: dermatological complications of immunosuppressive and anti-TNF therapy in inflammatory bowel disease
- Absorption sites of orally administered drugs in the small intestine
- STEROIDS AND STEROID-LIKE COMPOUNDS
- A Randomized Trial of Oral DHEA Treatment for Sexual Function, Well-Being, and Menopausal Symptoms in Postmenopausal Women with Low Libido
- The safety of 52 weeks of oral DHEA therapy for postmenopausal women
- Androgens and Antiandrogens
- Realising the therapeutic potential of neuroactive steroid modulators of the GABAA receptor
- Side effects of common acne treatments
- Herbal nano-formulations for topical delivery
- Estimating the Contribution of the Prostate to Blood Dihydrotestosterone
- Potassium channel openers: therapeutic potential in cardiology and medicine